Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06385171

Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation

Sponsor: Global Aesthetics LLC

View on ClinicalTrials.gov

Summary

A study conducting to see how well a treatment called Botulinum Toxin Type A works for reducing facial wrinkles. The study will help us understand if this treatment is safe and effective for making wrinkles on the face less noticeable.

Key Details

Gender

All

Age Range

20 Years - 65 Years

Study Type

OBSERVATIONAL

Enrollment

500

Start Date

2024-05-22

Completion Date

2027-01-05

Last Updated

2024-05-24

Healthy Volunteers

Not specified

Conditions

Interventions

DRUG

Botulinum toxin type A

The intervention involves the administration of Botulinum Toxin Type A, with dosages regulated according to FDA guidelines. Each injection site will receive a maximum of 4 units, adhering to the FDA's recommended dosage limits. Dosages administered will be tailored to each patient's needs and will be recorded in their individual patient information chart.

Locations (2)

Global Aesthetics LLC

Cisco, Texas, United States

Global Aesthetics LLC

Lubbock, Texas, United States